Bell Bank’s bluebird bio BLUE Stock Holding History

Bell Bank’s Portfolio BLUE Stock Details BLUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-139	Closed	-$229K	–	161
2019 Q2	$229K	Hold	139	–	–	0.05%	145
2019 Q1	$283K	Buy	+139	New	+$245K	0.08%	126
2018 Q4	–	Sell	-139	Closed	-$263K	–	138
2018 Q3	$263K	Buy	+139	New	+$287K	0.08%	132

Other funds holding BLUE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bell Bank's BLUE Position: Q3 2019 in Review

Bell Bank sold out of bluebird bio (BLUE) in Q3 2019, closing a stake of 139 shares — an estimated $229K sold.

Bell Bank first reported a position in BLUE in Q3 2018 and held it in 3 quarters. The position peaked at $283K in Q1 2019. 241 funds tracked by Wall St. Rank hold BLUE as of Q3 2019.

Bell Bank reported no remaining bluebird bio position as of Q3 2019 after selling out during the quarter.
Bell Bank sold 139 bluebird bio shares in Q3 2019, an estimated $229K.
Bell Bank first reported a position in bluebird bio in Q3 2018 and held it in 3 quarters.
Bell Bank's bluebird bio position peaked at $283K in Q1 2019.
241 funds tracked by Wall St. Rank held bluebird bio as of Q3 2019.

Based on Bell Bank's 13F filing for Q3 2019, filed 14 Nov 2019.